JOHN N KAPOOR
CIK 1033150 · President & CEO · last filed 2018-01-26
JOHN N KAPOOR is a President & CEO who has filed 45 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for AKRX, was dated Jan 26, 2018. Across all open-market trades the lifetime net is −$50.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $21.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$21.47M
5
45
-$50.88M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AKORN INC (AKRX) Delisted | Director | 2,413,432 | — | — | -$52.53M | 24 | 2018-01-26 |
| Insys Therapeutics, Inc. (INSY) Delisted | President & CEO | 42,479,792 | — | — | $1.57M | 9 | 2017-08-14 |
| NEOPHARM INC (NEOL) Delisted | Chairman of the Board | 5,210,151 | — | — | $84.1K | 7 | 2008-08-26 |
| INGN | Director | 3,354,995 | $6.40 | $21.47M | $0 | 3 | 2008-06-13 |
| OPTION CARE INC/DE (OPTN) Delisted | Director | 3,305,173 | $9.60 | $31.73M | $0 | 1 | 2007-06-07 |
Recent Filings
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-01-26 | AKORN INC (AKRX) Delisted | Mixed | +5,852 | -$16.1K | EDGAR |
| 2017-08-14 | Insys Therapeutics, Inc. (INSY) Delisted | Buy (P) | +35,000 | $312.7K | EDGAR |
| 2017-05-05 | AKORN INC (AKRX) Delisted | Grant (A) | +8,088 | $0 | EDGAR |
| 2017-02-23 | Insys Therapeutics, Inc. (INSY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-08-12 | Insys Therapeutics, Inc. (INSY) Delisted | Buy (P) | +11,400 | $211.7K | EDGAR |
| 2016-07-06 | AKORN INC (AKRX) Delisted | Grant (A) | +9,322 | $0 | EDGAR |
| 2015-11-16 | Insys Therapeutics, Inc. (INSY) Delisted | Buy (P) | +20,000 | $531.7K | EDGAR |
| 2015-11-13 | Insys Therapeutics, Inc. (INSY) Delisted | Buy (P) | +20,000 | $510.4K | EDGAR |
| 2015-05-07 | Insys Therapeutics, Inc. (INSY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-10 | AKORN INC (AKRX) Delisted | Buy (P) | +19,000 | $840.9K | EDGAR |